| Trial ID: | L3427 |
| Source ID: | NCT01963663
|
| Associated Drug: |
Metformin
|
| Title: |
Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Metformin|DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: Serum concentration of YKL-40, 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Tehran University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
84
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2012-11
|
| Completion Date: |
2013-04
|
| Results First Posted: |
|
| Last Update Posted: |
2013-10-16
|
| Locations: |
Diabetes Clinic, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, 13145-784, Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT01963663
|
